GlassScriptPhysician profile
Pamela Denson
NPI 1487854055
$699.11
in general payments reported to CMS, 2019-2025
16 companies · $68.09 in 2025
The $68.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.94 · 2021: $63.04 · 2022: $186 · 2023: $268 · 2024: $73.50 · 2025: $68.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $151.16 | 2022-2025 | Veozah |
| Myriad Women'S Health, INC. | $88.43 | 2023 | |
| Abbvie INC. | $85.22 | 2020-2024 | |
| Exeltis, USA INC. | $73.36 | 2022 | |
| Hologic Sales and Service, LLC | $54.29 | 2023 | Coolseal Generator |
| Mayne Pharma Commercial LLC | $49.82 | 2023-2025 | |
| Biogen, INC. | $43.13 | 2024 | |
| Therapeuticsmd, INC. | $27.48 | 2021-2022 | |
| Conmed Corporation | $23.16 | 2025 | Airseal, Vcare |
| Sumitomo Pharma America, INC. | $21.93 | 2023 | Gemtesa |
| Flowonix Medical Incorporated | $19.28 | 2020 | |
| Shield Therapeutics INC | $14.37 | 2024 | |
| Becton, Dickinson and Company | $14.07 | 2021 | |
| Innovation Technologies INC | $13.99 | 2025 | Irrisept |
| Pfizer INC. | $13.49 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $5.93 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Denson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.